Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
A study suggests that dispersal - through air or rain, for example - plays a major role in microbial succession after a destructive fire.
TeselaGen Biotechnology has announced that it is extending its relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract.
Engineers have developed nanoparticles, fashioned from plant viruses, that can deliver pesticide molecules to soil depths that were previously unreachable.
Researchers find that warming trends will likely result in major disturbances of networks of fungi, potentially harming forest resilience.
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
A study suggests that dispersal - through air or rain, for example - plays a major role in microbial succession after a destructive fire.
Researchers find that warming trends will likely result in major disturbances of networks of fungi, potentially harming forest resilience.
The Microbiologist has been shortlisted for the MEMCOM award for Best Magazine Launch or Re-launch. Subscribe now to make sure you don't miss out on the latest news, features, careers and opinion.
SubscribeTeselaGen Biotechnology has announced that it is extending its relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract.
Researchers led by Osaka University develop a new gene modification technique known as NICER that significantly reduces off-target mutations in DNA.
Three companies have received a total of €1.8 million from EIT Food to develop innovative products to reduce the cost of producing cultivated meat within the next two years.
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
Engineers have developed nanoparticles, fashioned from plant viruses, that can deliver pesticide molecules to soil depths that were previously unreachable.
An experimental mRNA vaccine provides protection in preclinical animal models against infection from Borrelia burgdorferi, the bacterium that causes Lyme disease, according to new research.
TeselaGen Biotechnology has announced that it is extending its relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract.
The Seattle-based biotech company has developed a natural solution to eliminate the microorganisms in the cow gut that produces methane gas, a major cause of global warming.
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people.